Results 191 to 200 of about 886,649 (291)

Risk factors for adults with Philadelphia‐chromosome‐positive acute lymphoblastic leukaemia in remission treated with allogeneic bone marrow transplantation: the potential of real‐time quantitative reverse‐transcription polymerase chain reaction [PDF]

open access: bronze, 2002
Seok Lee   +11 more
openalex   +1 more source

Efficacy and safety of olverembatinib as maintenance therapy after allogeneic hematopoietic cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemia. [PDF]

open access: yesAnn Hematol
Kong J   +14 more
europepmc   +1 more source

High-dose imatinib mesylate therapy in newly diagnosed Philadelphia chromosome–positive chronic phase chronic myeloid leukemia [PDF]

open access: bronze, 2003
Hagop M. Kantarjian   +12 more
openalex   +1 more source

Patient-reported outcomes in Philadelphia chromosome-positive acute lymphoblastic leukemia patients treated with ponatinib or imatinib: results from the PhALLCON trial. [PDF]

open access: yesLeukemia
Ashaye A   +14 more
europepmc   +1 more source

Philadelphia chromosome-negative engraftment after autologous transplantation with granulocyte-macrophage colony-stimulating factor for chronic myeloid leukemia

open access: hybrid, 1999
Douglas E. Gladstone   +11 more
openalex   +1 more source

Early prediction of response in patients with relapsed or refractory Philadelphia chromosome–positive acute lymphoblastic leukemia (Ph+ALL) treated with imatinib [PDF]

open access: bronze, 2003
Barbara Waßmann   +17 more
openalex   +1 more source

Case report: An intriguing case of Philadelphia chromosome-positive acute lymphoblastic leukemia recurrence. [PDF]

open access: yesFront Oncol
Peccatori N   +8 more
europepmc   +1 more source

Analysis of the impact of imatinib mesylate therapy on the prognosis of patients with Philadelphia chromosome–positive chronic myelogenous leukemia treated with interferon‐α regimens for early chronic phase [PDF]

open access: bronze, 2003
Hagop M. Kantarjian   +9 more
openalex   +1 more source

Home - About - Disclaimer - Privacy